ROCKWELL MEDICAL, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ROCKWELL MEDICAL, INC. (RMTI) reported Adjustments to Additional Paid in Capital, Warrant Issued of $247.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-26
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $247.00K.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $501.00K.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2011-12-31 was $207.05K.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2011-09-30 was $41.20K.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $247.00K.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $501.00K.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, warrant issued for fiscal 2011 was $312.32K, a 51.19% decline from fiscal 2010.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, warrant issued for fiscal 2010 was $639.91K, a 84.97% decline from fiscal 2009.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $247.00K 10-K · filed 2026-03-26 | ||||
| 2024-03-31 | $247.00K 10-Q · filed 2025-11-12 | ||||
| 2020-12-31 | $501.00K 10-K · filed 2022-04-08 | ||||
| 2020-03-31 | $501.00K 10-Q · filed 2021-11-15 | $500.74K 10-Q · filed 2020-05-11 | |||
| 2011-12-31 | $207.05K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $248.25K derived: sum of 2 quarters · filed 2014-03-07 | $312.32K 10-K · filed 2014-03-07 | ||
| 2011-09-30 | $41.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $105.27K 10-Q · filed 2011-11-04 | |||
| 2011-06-30 | $64.07K 10-Q · filed 2011-08-05 | ||||
| 2010-12-31 | $639.91K 10-K · filed 2013-03-18 | ||||
| 2009-12-31 | $4.26M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |